U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843537) titled 'MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study' on Sept. 21.
Brief Summary: This study is being done to test whether adding two drugs-disulfiram and copper gluconate-to radiation therapy can help overcome this resistance and improve treatment outcomes. When disulfiram is combined with copper, it forms a substance that may increase stress within cancer cells and lead to a specific type of cancer cell death knowns as "cuproptosis".
Study Start Date: March 01, 2027
Study Type: INTERVENTIONAL
Condition:
Thoracic Cancer
Intervention:
DRUG: D...